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Circular duplex reverse transcripts of the genome of a strain of Abelson murine
leukemia virus that encodes a 160,000-molecular-weight protein were isolated,
cleaved with Hindlll restriction endonuclease, and cloned into the unique HindIII
site of lambda phage Charon 21A. Recombinant phage clones, some of which
were infectious in transfection assays, were found to contain a 789-base-pair
region specific for Abelson murine leukemia virus; this region is not found in other
strains of this virus. The extra sequence was localized by restriction endonuclease
and electron microscopic heteroduplex analysis. Sequence analysis showed no
homology at the ends of the extra sequence, implying that it was deleted by an
event that did not utilize sequence homology. The sequence of this unique region
has an open reading frame through its entirety.
Abelson murine leukemia virus (A-MuLV) is a
replication-defective retrovirus capable of trans-
forming mouse lymphoid (1, 13) and fibroblastic
(15) cells. The genome of this virus is a hybrid
RNA molecule containing portions of the paren-
tal Moloney MuLV at its ends and a large
substitution, termed v-abl, in the center (16).
This central substitution is homologous to a
cellular gene, termed c-abl, which is apparently
interrupted by several intervening sequences not
present in the viral genome (7).
Several variants ofA-MuLV have been isolat-
ed with alterations in the central portion of the
genome. These variants encode related mem-
brane-associated proteins ranging in size from
160,000 to 85,000 daltons (14). The largest
genome, that ofA-MuLV(P160), is approximate-
ly 6.2 kilobases (kb) long and is known to encode
the largest of these polypeptides, termed P160.
Other genomes, including those encoding pro-
teins P120, P100, and P90, are smaller and
apparently share a common deletion of 0.7 to 0.8
kb with that encoding P160 (7, 9). A transforma-
tion-defective genome (21) encoding a protein
termed P92td has suffered yet another deletion
(9).
To isolate DNA clones representing the
genome of A-MuLV(P160), virus was isolated
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from the A-MuLV(P160)-transformed NIH 3T3
fibroblast cell line AN-P160-54 (9), which had
been coinfected with the clone 3A strain of
Moloney MuLV. The virus was used to infect
sensitive NIH 3T3 cells from which supercoiled
circular duplex A-MuLV(P160) DNA was isolat-
ed (7). This DNA was cleaved with HindIII
endonuclease and cloned into the unique
HindIlI site of lambda phage Charon 21A (20).
A total of 10 independent isolates that hybrid-
ized (4) to an abl-specific probe (plasmid
pAB3SUB3) (7) were grown into phage stocks,
the DNA from which was characterized for
restriction endonuclease cleavage sites. Prelimi-
nary restriction maps of these 10 clones were
prepared by using the abl-specific probe to iden-
tify (19) major restriction fragments. Five of the
clones appeared to contain full-length A-
MuLV(P160) genomes with one long terminal
repeat (LTR) sequence (6.2 kb total), and three
had apparently full-length genomes with two
tandem LTR sequences (6.7 kb total). The re-
maining two clones contained large internal de-
letions (1.0 and 0.2 kb) and were not character-
ized further (Table 1).
Comparison of the restriction enzyme cleav-
age maps of these clones with those of other
strains ofA-MuLV DNA (9) suggests that the A-
MuLV(P160) genome contains an extra 0.7 to
0.8 kb when compared with the P120, P100, or
P90 strains and that a new Sacd site is present in
this extra DNA. This unique sequence was
localized near the center of the abl region. In
addition, the LTR region of the P160 clones was
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FIG. 1. (A) Heteroduplex (diagrammed in inset) between cloned inserts from A-MuLV(P160) and A-
MuLV(P90). (B) Heteroduplex (diagrammed in inset) between cloned inserts from A-MuLV(P160) and A-
MuLV(P92td.
approximately 80 base pairs (bp) shorter than heteroduplexes (6) between XAB160-1 and XAB3
that of the other A-MuLV genomes examined. [derived from A-MuLV(P90)] (7), revealed com-
A prototype clone with one LTR (XAB160-1) plete homology, except for a single loop, 0.73 kb
was chosen for further analysis. Examination of in size, mapping 1.7 kb from one end of the
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TABLE 1. Properties of A-MuLV(P160) clones
Clone No. of LTRs Transforma-tiona
AAB160-1 1
XAB160-2 1 +
XAB160-3 1 +
XAB160-5 2 +
XAB160-6 1
XAB1609b 1
XAB160-12 2 +d
XAB160-13 2
XAB160-15 1 +d
XAB16016c 1
a Each DNA preparation was cleaved with HindIII
endonuclease and religated to produce some DNA
fragments containing a nonpermuted copy of the pro-
virus. These DNA samples were then cotransfected as
described in the text with a 10-fold molar excess of
DNA of a biologically active proviral clone of
Moloney MuLV termed pZAP (18). The cells were
replated 1 day later, and foci were scored after 15 to 20
days in culture.
b Deletion of 1.0 kb in 2.75-kb Sacl-Sacl fragment
(Fig. 3).
c Deletion of 0.2 kb in 2.75-kb SacI-SacI fragment
(Fig. 3).
d Transformed cells produced P160.
inserts (Fig. 1A). Thus, the extra DNA con-
tained in the A-MuLV(P160) genome apparently
lies in a single contiguous stretch. Heterodu-
plexes between XAB160-1 and XAB2 [derived
from A-MuLV(P92td)] (7) showed two separate
deletion loops 0.7 and 0.6 kb in size, separated
by 0.3 kb of duplex DNA (Fig. 1B). These data
(summarized in Fig. 2) show that the two dele-
tions present in A-MuLV(P92td) do not overlap.
To determine the sequence of the unique
information in A-MuLV(P160), a 0.94-kb PstI
fragment of XAB160-3, which appeared to con-
tain the entire unique region, was subcloned into
the PstI site of plasmid pBR322 (5). Comparison
of the sequence (12) of this fragment with that of
an A-MuLV(P90) clone (Lee et al., manuscript
in preparation) shows that the unique region is
789 bp long and has a single open reading frame
through its entirety. The sequence itself will be
published as part of the complete A-MuLV
sequence (manuscript in preparation). Certain
restriction enzyme cleavage sites are shown in
Fig. 3. DNA sequence and restriction fragment
analysis placed the 3' boundary of the A-
MuLV(P160)-specific insert 1.75 kb interior to
the 3' end of the total A-MuLV(P160) genome,
as compared with 1.69 ± 0.05 kb estimated by
heteroduplex analysis. Agreement between
these two estimates, and between the insert size
as determined by DNA sequencing (789 bp) and
by electron microscopy (725 ± 48 and 734 ± 62
bp) (Fig. 2), is reasonably good.
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FIG. 2. Analysis of heteroduplex data involving
cloned A-MuLV molecules. Heteroduplex figures
were identified on 8 by 10 in (20 by 25 cm) photograph-
ic prints. Relative segment lengths were determined
from duplicate scans with an X-Y digitizer kindly
made available by Jonathan King. (A) A-
MuLV(P160)-A-MuLV(P90) heteroduplex. (B) A-
MuLV(P160)-A-MuLV(P92td) heteroduplex. The seg-
ments identified in the diagram based on the number of
pictures (n) indicated in parentheses are represented
first as average fractional lengths (± standard error of
the mean), from which the sizes of the inserted seg-
ments are estimated.
An important aspect of the unique sequence in
XAB160-3 is that there is no homology between
the end points of the region (Fig. 4), implying
that if (as seems most likely) A-MuLV(P160)
suffers a deletion to produce the A-MuLV(P120)
genome, that deletion involves no homology. In
addition, the sequence at the deletion is not
compatible with the idea that an aberrant splic-
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FIG. 3. Summary map of A-MuLV(P160) genomes
derived from electrophoresis and heteroduplex data.
(A) Insert with two LTRS. (B) Detail of (A). , v-
abl sequences. Scale is indicated at the right. Enzyme
cleavage sites are indicated as follows: H, HindIll; S,
Sacl; P, PstI; T, TaqI; SU, Sau96I. The size of the A-
MuLV(P160)-specific insert (mm. is based on DNA
sequence data. The data in (B) are derived largely from
analysis of the subcloned PstI fragment.
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A-MuLV(P160) Unique Sequence
Asp Ala Pro Asp Ser Ser Pro Gly Ser
-AT GCG CCT GAC--- TCC AGC CCT GGC T-
\ 30 810 /
Ala Glu GIn Lys [Al Ser Pro Pro Ser
---GCT GAG CAG AAA G\C0 AGC CCT CCC AGC---
20 820
A-MuLV(P120) Sequence
FIG. 4. DNA sequences at the junctions of the A-
MuLV(P160)-specific DNA insert. Base pairs are
numbered starting with the 5' terminus of the PstI
fragment. The boundaries of the surrounding A-
MuLV(P120) sequence are also indicated. Written
above each triplet is the corresponding amino acid,
and in the case of the A-MuLV(P120) sequence, the
amino acid (in brackets) replaced in A-MuLV(P160)
because the insert occurred within a codon.
ing event causes the removal of the 789 bp; no
homology to the consensus sequences at splice
joints (2) was detected. One mechanism that
could generate the deletion is an unequal, illegit-
imate recombination between A-MuLV(P160)
genomes, such as that postulated by Goldfarb
and Weinberg (10) to occur between deleted
Harvey sarcoma virus and Moloney MuLV ge-
nomes.
The cloned permuted A-MuLV(P160) ge-
nomes were tested for biological activity in a
transfection assay (8) as modified by Andersson
et al. (3) from the method ofGraham and van der
Eb (11), with NIH 3T3 cells used as indicator
cells. Of eight independent clones lacking a
deletion in the abl sequence, five were capable
of transforming mouse NIH 3T3 cells (Table 1).
Preliminary data (Rotter, unpublished) are con-
sistent with the production of the P160 protein
by most, if not all, of these transfectants. Three
of the infective clones contained one LTR; the
other two contained two LTRs. The LTRs of
these A-MuLV(P160) clones were shorter by
approximately 80 bp than the LTRs of other A-
MuLV strains. The exact position of this dele-
tion has not yet been determined, but it might
well correspond to loss of one of the tandemly
repeated 75-bp sequences starting 117 and 192
bp from the 5' end of the LTR in M-MuLV (17).
The biological significance of this deletion is not
yet clear. Since it was present in all 10 of the A-
MuLV(P160) clones examined, it presumnably
preexisted in the A-MuLV(P160) RNA and
hence was compatible with biological transfor-
mation.
The acquisition and initial characterization of
A-MuLV(P160) clones should permit more de-
tailed study of the abl sequence segments in the
mouse genome and of structure-activity relation-
ships within the family of transformation-associ-
ated A-MuLV proteins.
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